Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Stratec Se stock

SBS.DE
DE000STRA555
STRA55

Price

0
Today +/-
-0
Today %
-0 %

Stratec Se stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Stratec Se stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Stratec Se stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Stratec Se stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Stratec Se's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Stratec Se Stock Price History

DateStratec Se Price
1/17/20250 undefined
1/16/202530.00 undefined
1/15/202529.90 undefined
1/14/202528.25 undefined
1/13/202527.55 undefined
1/10/202529.05 undefined
1/9/202529.75 undefined
1/8/202529.25 undefined
1/7/202530.00 undefined
1/6/202530.60 undefined
1/3/202529.75 undefined
1/2/202529.75 undefined
12/30/202429.80 undefined
12/27/202430.10 undefined
12/23/202429.75 undefined
12/20/202429.00 undefined

Stratec Se Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Stratec Se, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Stratec Se from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Stratec Se’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Stratec Se. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Stratec Se’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Stratec Se’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Stratec Se’s growth potential.

Stratec Se Revenue, EBIT and net profit per share

DateStratec Se RevenueStratec Se EBITStratec Se Net Income
2029e379.46 M undefined0 undefined0 undefined
2028e360.98 M undefined60.38 M undefined41.73 M undefined
2027e327.83 M undefined49.85 M undefined35.11 M undefined
2026e297.53 M undefined39.5 M undefined29.34 M undefined
2025e275.4 M undefined32.86 M undefined23.6 M undefined
2024e258.26 M undefined26.26 M undefined18.13 M undefined
2023261.91 M undefined25.71 M undefined13.07 M undefined
2022274.63 M undefined42.75 M undefined29.22 M undefined
2021287.34 M undefined50.45 M undefined39.96 M undefined
2020250.1 M undefined35.29 M undefined25.18 M undefined
2019214.16 M undefined18.21 M undefined14.44 M undefined
2018187.82 M undefined14.1 M undefined8.97 M undefined
2017207.48 M undefined25.59 M undefined25.64 M undefined
2016184.91 M undefined23.97 M undefined19.5 M undefined
2015146.89 M undefined27.36 M undefined22.08 M undefined
2014144.86 M undefined24.05 M undefined19.77 M undefined
2013128 M undefined19.5 M undefined15.5 M undefined
2012122.4 M undefined17.6 M undefined14 M undefined
2011118.7 M undefined21.8 M undefined15.3 M undefined
2010103.8 M undefined17.6 M undefined13 M undefined
200980.3 M undefined14.7 M undefined11.7 M undefined
200862.1 M undefined11.3 M undefined6.1 M undefined
200768.3 M undefined14.3 M undefined10 M undefined
200669.1 M undefined10.8 M undefined7.7 M undefined
200547.6 M undefined7.2 M undefined4.4 M undefined
200440.6 M undefined4.7 M undefined2.8 M undefined

Stratec Se Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
11811272632404769686280103118122128144146184207187214250287274261258275297327360379
--27.2737.50145.45-3.7023.0825.0017.5046.81-1.45-8.8229.0328.7514.563.394.9212.501.3926.0312.50-9.6614.4416.8214.80-4.53-4.74-1.156.598.0010.1010.095.28
72.7387.5063.6437.0442.3146.8845.0048.9446.3855.8858.0655.0053.4055.0831.9732.0330.5637.6733.1530.9225.6723.3627.2030.3128.8324.5224.8123.2721.5519.5717.7816.89
8771011151823323836445565394144556164485068877964000000
1000112471061113151415192219258142539291318232935410
------100.00100.0075.0042.86-40.0083.3318.1815.38-6.677.1426.6715.79-13.6431.58-68.0075.0078.5756.00-25.64-55.1738.4627.7826.0920.6917.14-
--------------------------------
--------------------------------
99999.79.91010.511.411.411.411.411.711.711.711.811.8311.9211.9411.9812.0312.0612.1512.1812.1712.16000000
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Stratec Se Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Stratec Se is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
1.40.500.10.80.91.21012.420.319.521.813.719.813.521.147.0457.9230.7136.6424.6324.0339.1447.4924.0735.58
21.74.16.744.46.710.58.910.69.79.915.815.323.823.418.9624.0538.8939.1335.8838.937.9341.2457.8559.94
0.81.71.51.11.41.62.23.66.2666.46.87.410.45.84.848.059.2211.185.488.528.197.429.197.2
4.16.78.89.511.312.210.912.714.71624.131.635.239.544.118.118.0716.0224.5227.8858.5355.9868.0388.77117.63142.63
00000000000.20.20.20.40.60.91.12.112.592.162.671.7133.112.652.63
8.310.614.417.417.519.12136.842.252.959.569.971.782.492.469.390.01108.15105.93116.98127.19129.13156.28188.02211.39247.98
22.72.52.43.44.14.45.75.666.38.916.417.217.11715.9519.632.7935.739.5155.9265.4767.467484
000.300000.833.10.90.30.30.40.40.40.260.180.380.240.460.450.583.573.543.58
0.10.10.10.100000000000000009.6715.6219.518.2116.6413.38
0.10.100.30.30.30.20.25.44.12.74.45.75.96.225.825.4825.8775.9468.7157.0256.4250.7551.3751.6262.13
000000000.90.80.62.14.54.64.54.44.795.1342.8442.0241.2540.6737.863836.6651.16
00000.10.10.10.10000.10.30.61.30.91.260.020.10.130.21.211.461.93.674.35
2.22.92.92.83.84.54.76.814.91410.515.827.228.729.548.547.7450.79152.04146.8148.1170.28175.62180.51186.12218.6
10.513.517.320.221.323.625.743.657.166.97085.798.9111.1121.9117.8137.75158.94257.97263.78275.29299.41331.9368.53397.5466.58
                                                   
2.62.6333.33.33.33.711.311.411.411.411.611.711.711.811.811.8511.8611.9211.9712.0312.112.1312.1612.16
2.42.422444.115.99.910.610.711.213.915.316.217.218.1320.0620.4422.4224.1226.4629.8732.2235.1536.27
1.41.71.92.83.95.68.11218.526.830.438.14655.462.967.880.4894.31104.55121.06116.35120.98136.05165.12182.82184.1
000000000.5-0.2-0.7-1.40.81.11.30.61.864.234.570.01-0.14-0.37-5.41-3.67-4.910.83
0000000000000000001.042.53000000
6.46.76.97.811.212.915.531.640.248.651.859.372.383.592.197.4112.26130.45142.46157.93152.29159.1172.61205.79225.22233.36
0.91.12.24.33.11.72.12.52.92.63.63.42.844.34.42.823.447.16.936.4612.278.4911.410.8721.45
00000000001.32.62.42.43.43.32.395.529.614.2911.9911.215.0614.5913.3911.9
0.41.320.50.81.90.65.788.77.912.711.410.111.535.758.228.496.5119.598.756.8212.9528.9116.04
00000000000000000000000000
0.21.13.33.922.52.41.81.30.30.40.50.60.81.21.94.631.4969.010.971.013.455.36.737.0847.04
1.53.57.58.75.96.15.11012.211.613.219.217.217.320.412.615.5918.6794.228.739.0535.6735.6745.6760.2596.43
11.61.11.72.13.12.41.72.55.15.75.67.49.27.56.64.483.612.5161.5368.5389.81104.2878.5680.0794.34
0.810.80.60.50.40.30.42.21.51.11.62.11.42.11.45.575.5814.5711.047.536.937.388.799.4110.08
0.90.60.91.51.81.52.500.1000.10.30000.060.84.354.677.98812.0429.7522.632.41
2.73.22.83.84.455.22.14.86.66.87.39.810.69.6810.119.9921.4377.2484.03104.74123.69117.1112.07136.82
4.26.710.312.510.311.110.312.11718.22026.52727.93020.625.728.66115.63105.94123.08140.41159.36162.77172.32233.25
10.613.417.220.321.52425.843.757.266.871.885.899.3111.4122.1118137.96159.11258.09263.87275.37299.5331.97368.56397.54466.61
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Stratec Se provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Stratec Se's financial health and stability.

Assets

Stratec Se's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Stratec Se must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Stratec Se after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Stratec Se's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
10001124796111315131519221925814253929
00000011122233368611182118221816
0000000000000-10131-3-4-1-100-1
-4-2-1-20-2-1-40-2-8-6-17-12-16-27-6-18-13-22-18-21-5-50
000000000052341203735841016
00000000000000000001,00001,0001,0001,0001,000
0000011144443753066227145
-20-10102189410110223392616291121316310
-1-100-1-1-1-2-1-1-1-2-7-2-2-10-6-8-9-15-19-26-25-20-19
-1-100-1-1-1-2-6-2-1-4-8-2-2-10-6-8-86-15-10-27-21-20-18
00000000-500-2000000-76080300
0000000000000000000000000
0111-110-1010011-10-1-249-871312-24-4
40002001200-102100010112211
31110101000-3-4-1-2-6-5-8-840-15055-34-14
-------------------------
-20000000-1-1-2-3-5-5-6-6-7-8-8-9-9-9-10-10-11
000000082701-76-67259-29-20-1149-24
-4.03-2.02-2.01-1.31-0.17-1.261.28-1.027.727.752.888.66-6.158.280.2313.8333.0617.256.3314.32-7.49-5.586.2743.24-8.74
0000000000000000000000000

Stratec Se stock margins

The Stratec Se margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Stratec Se. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Stratec Se.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Stratec Se's sales revenue. A higher gross margin percentage indicates that the Stratec Se retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Stratec Se's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Stratec Se's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Stratec Se's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Stratec Se. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Stratec Se's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Stratec Se Margin History

Stratec Se Gross marginStratec Se Profit marginStratec Se EBIT marginStratec Se Profit margin
2029e24.76 %0 %0 %
2028e24.76 %16.73 %11.56 %
2027e24.76 %15.21 %10.71 %
2026e24.76 %13.28 %9.86 %
2025e24.76 %11.93 %8.57 %
2024e24.76 %10.17 %7.02 %
202324.76 %9.82 %4.99 %
202228.94 %15.57 %10.64 %
202130.53 %17.56 %13.91 %
202027.58 %14.11 %10.07 %
201923.77 %8.5 %6.74 %
201825.68 %7.51 %4.78 %
201731.21 %12.33 %12.36 %
201633.5 %12.96 %10.54 %
201537.5 %18.63 %15.03 %
201431.02 %16.6 %13.65 %
201332.66 %15.23 %12.11 %
201232.35 %14.38 %11.44 %
201154.84 %18.37 %12.89 %
201053.47 %16.96 %12.52 %
200955.92 %18.31 %14.57 %
200858.94 %18.2 %9.82 %
200755.93 %20.94 %14.64 %
200646.74 %15.63 %11.14 %
200549.79 %15.13 %9.24 %
200446.31 %11.58 %6.9 %

Stratec Se Stock Sales Revenue, EBIT, Earnings per Share

The Stratec Se earnings per share therefore indicates how much revenue Stratec Se has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Stratec Se earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Stratec Se's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Stratec Se’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Stratec Se's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Stratec Se Revenue, EBIT and net profit per share

DateStratec Se Sales per ShareStratec Se EBIT per shareStratec Se Earnings per Share
2029e31.21 undefined0 undefined0 undefined
2028e29.69 undefined0 undefined3.43 undefined
2027e26.96 undefined0 undefined2.89 undefined
2026e24.47 undefined0 undefined2.41 undefined
2025e22.65 undefined0 undefined1.94 undefined
2024e21.24 undefined0 undefined1.49 undefined
202321.54 undefined2.11 undefined1.07 undefined
202222.56 undefined3.51 undefined2.4 undefined
202123.59 undefined4.14 undefined3.28 undefined
202020.58 undefined2.9 undefined2.07 undefined
201917.75 undefined1.51 undefined1.2 undefined
201815.61 undefined1.17 undefined0.75 undefined
201717.31 undefined2.14 undefined2.14 undefined
201615.49 undefined2.01 undefined1.63 undefined
201512.32 undefined2.3 undefined1.85 undefined
201412.24 undefined2.03 undefined1.67 undefined
201310.85 undefined1.65 undefined1.31 undefined
201210.46 undefined1.5 undefined1.2 undefined
201110.15 undefined1.86 undefined1.31 undefined
20108.87 undefined1.5 undefined1.11 undefined
20097.04 undefined1.29 undefined1.03 undefined
20085.45 undefined0.99 undefined0.54 undefined
20075.99 undefined1.25 undefined0.88 undefined
20066.06 undefined0.95 undefined0.68 undefined
20054.53 undefined0.69 undefined0.42 undefined
20044.06 undefined0.47 undefined0.28 undefined

Stratec Se business model

The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.com.

Stratec Se SWOT Analysis

Strengths

Stratec SE holds a dominant position in the market, offering unique and innovative products/services that have gained significant traction among customers.

The company possesses strong technological expertise, allowing it to develop cutting-edge solutions that provide a competitive edge over rivals.

Stratec SE boasts an efficient supply chain management system, ensuring timely delivery of products to customers while minimizing costs.

The company invests heavily in research and development, continuously enhancing its product portfolio and offering innovative solutions to meet market demands.

Weaknesses

Stratec SE relies heavily on a few key customers for a significant portion of its revenue, making it vulnerable to potential loss if these customers switch to competitors.

The company's operations are primarily focused in specific geographic regions, limiting its exposure to global markets and potential opportunities.

Stratec SE's product portfolio is relatively narrow, which could limit its ability to cater to diverse customer requirements and adapt to changing market dynamics.

Opportunities

The global medical devices market is experiencing significant growth, presenting Stratec SE with opportunities to expand its customer base and increase revenues.

Advancements in technologies like artificial intelligence and Internet of Things offer Stratec SE the chance to develop innovative solutions and gain a competitive edge in the market.

The company can explore untapped markets and expand its operations internationally, diversifying its customer base and reducing dependency on specific regions or customers.

Threats

The medical devices market is highly competitive, with numerous players vying for market share, which could potentially erode Stratec SE's market position and profitability.

The industry is subject to stringent regulations and compliance requirements, and any changes in regulations could pose challenges for Stratec SE in terms of product development and market access.

Rapid technological advancements may render Stratec SE's existing products/services obsolete if the company fails to adapt and innovate accordingly.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Stratec Se Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Stratec Se historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Stratec Se shares outstanding

The number of shares was Stratec Se in 2024 — This indicates how many shares 12.159 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Stratec Se earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Stratec Se's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Stratec Se’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Stratec Se's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Stratec Se stock splits

In Stratec Se's history, there have been no stock splits.

Stratec Se dividend history and estimates

In 2024, Stratec Se paid a dividend amounting to 0.55 EUR. Dividend means that Stratec Se distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Stratec Se provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Stratec Se’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Stratec Se's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Stratec Se Dividend History

DateStratec Se Dividend
2029e1.05 undefined
2028e1.05 undefined
2027e1.05 undefined
2026e1.05 undefined
2025e1.05 undefined
2024e1.05 undefined
20230.97 undefined
20220.95 undefined
20210.9 undefined
20200.84 undefined
20190.82 undefined
20180.8 undefined
20170.77 undefined
20160.75 undefined
20150.7 undefined
20140.6 undefined
20130.56 undefined
20120.55 undefined
20110.5 undefined
20100.45 undefined
20090.35 undefined
20080.22 undefined
20070.15 undefined
20060.1 undefined
20050.05 undefined
20040.03 undefined

Stratec Se dividend payout ratio

In 2024, Stratec Se had a payout ratio of 34.29%. The payout ratio indicates the percentage of the company's profits that Stratec Se distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Stratec Se represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Stratec Se could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Stratec Se's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Stratec Se Payout Ratio History

DateStratec Se Payout ratio
2029e35.64 %
2028e35.88 %
2027e35.48 %
2026e35.58 %
2025e36.58 %
2024e34.29 %
202335.86 %
202239.57 %
202127.44 %
202040.58 %
201969.35 %
2018108.11 %
201736.15 %
201645.92 %
201537.78 %
201435.92 %
201342.75 %
201246.22 %
201138.17 %
201040.18 %
200934.31 %
200840.74 %
200717.24 %
200614.73 %
200511.93 %
20049.54 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Stratec Se.

Stratec Se latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.38 0.22  (-42.68 %)2024 Q3
6/30/20240.33 0.35  (5.01 %)2024 Q2
9/30/20230.62 0.42  (-31.83 %)2023 Q3
3/31/20230.24 0.18  (-25.74 %)2023 Q1
12/31/20220.61 0.42  (-30.69 %)2022 Q4
3/31/20221.01 0.99  (-1.98 %)2022 Q1
9/30/20210.79 0.99  (25.67 %)2021 Q3
12/31/20200.84 0.95  (13.32 %)2020 Q4
9/30/20200.65 0.67  (3.65 %)2020 Q3
6/30/20200.68 0.68  (0.49 %)2020 Q2
1
2
3
4

Eulerpool ESG Scorecard© for the Stratec Se stock

Eulerpool World ESG Rating (EESG©)

89/ 100

🌱 Environment

98

👫 Social

99

🏛️ Governance

70

Environment

Scope 1 - Direct Emissions
639.1
Scope 2 - Indirect emissions from purchased energy
1,376.7
Scope 3 - Indirect emissions within the value chain
9,303.6
Total CO₂ emissions
2,015.8
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees36.1
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Stratec Se shareholders

%
Name
Stocks
Change
Date
40.54280 % Leistner Family4,930,005011/21/2023
5.01545 % Invesco Advisers, Inc.609,879011/21/2023
4.98192 % Brown Capital Management, LLC605,80209/13/2023
3.28947 % Union Investment Privatfonds GmbH400,00060,03410/25/2024
3.00906 % Juno Investment Partners365,90209/13/2023
2.98210 % Allianz Global Investors GmbH362,62309/13/2023
2.84780 % Columbia Threadneedle Investments (UK)346,29209/13/2023
1.99659 % Janus Henderson Investors242,7854,7819/30/2024
1.70373 % The Vanguard Group, Inc.207,174-9619/30/2024
1.67542 % Comgest S.A.203,73106/30/2024
1
2
3
4
5
...
10

Stratec Se Executives and Management Board

Mr. Marcus Wolfinger

(55)
Stratec Se Chairman of the Management Board, Chief Executive Officer
Compensation 2.1 M

Dr. Robert Siegle

(55)
Stratec Se Director - Finance and Human Resources, Member of the Board of Management (since 1998)
Compensation 1.36 M

Dr. Claus Vielsack

(55)
Stratec Se Member of the Management Board, Director - Product Development
Compensation 1.22 M

Dr. Frank Hiller

(56)
Stratec Se Independent Deputy Chairman of the Supervisory Board (since 2019)
Compensation 44,000

Prof. Dr. Georg Heni

(65)
Stratec Se Independent Chairman of the Supervisory Board (since 2022)
Compensation 39,000
1
2

Stratec Se Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Hologic Stock
Hologic
SupplierCustomer0,76-0,280,280,210,350,52
DiaSorin SpA Stock
DiaSorin SpA
SupplierCustomer0,670,880,880,930,920,69
Quanterix Stock
Quanterix
SupplierCustomer0,510,800,790,820,63
Medicon Hellas Stock
Medicon Hellas
SupplierCustomer-0,270,720,510,16-0,43
Quotient Stock
Quotient
SupplierCustomer-0,360,710,660,790,57-0,13
1

Most common questions regarding Stratec Se

What values and corporate philosophy does Stratec Se represent?

Stratec SE represents a strong set of values and corporate philosophy. With a focus on innovation and quality, the company aims to provide cutting-edge solutions in the field of automation and instrumentation for medical diagnostics. Stratec SE puts a strong emphasis on customer satisfaction and long-term partnerships, striving for continuous improvement and excellence. By fostering a culture of collaboration, integrity, and professionalism, the company aims to drive sustainable growth and deliver value to its shareholders. Stratec SE's commitment to delivering high-performance products and services, coupled with its dedication to corporate responsibility, sets it apart in the industry.

In which countries and regions is Stratec Se primarily present?

Stratec SE is primarily present in various countries and regions. As a global company, its presence extends across Europe, North America, and Asia. Stratec SE operates in countries such as Germany, Switzerland, the United States, China, and Japan, among others. With its strong international footprint, Stratec SE has established itself as a leading provider of innovative solutions in the fields of in-vitro diagnostics and life sciences.

What significant milestones has the company Stratec Se achieved?

Stratec SE, a renowned stock company, has accomplished several notable milestones throughout its journey. One prominent achievement is the successful development of innovative laboratory and diagnostic solutions for the global healthcare industry. Stratec SE has also gained recognition for its strategic partnerships and collaborations, fostering growth and expanding its market presence. Moreover, the company has consistently delivered strong financial performance, achieving sustainable revenue growth and enhancing shareholder value. Stratec SE's commitment to continuous innovation, dedication to quality, and focus on customer satisfaction has positioned it as a key player in the industry, ensuring its ongoing success and reputation as a trusted stock investment.

What is the history and background of the company Stratec Se?

Stratec SE, a leading global supplier of laboratory automation and diagnostic solutions, has a rich history and background. Established in 1979 in Birkenfeld, Germany, the company has grown from a small start-up to a renowned player in the life science industry. Stratec SE specializes in developing innovative technologies and devices that enable faster and more efficient diagnostics and research processes. With a strong focus on customer satisfaction and strategic partnerships, Stratec SE has expanded its presence worldwide. Today, the company serves a diverse range of customers, including pharmaceutical firms, medical device manufacturers, and research institutions. Stratec SE's dedication to technological advancement and commitment to quality make it a trusted name in the industry.

Who are the main competitors of Stratec Se in the market?

The main competitors of Stratec SE in the market include companies like Thermo Fisher Scientific, Becton, Dickinson and Company, PerkinElmer Inc., and Bio-Rad Laboratories.

In which industries is Stratec Se primarily active?

Stratec SE is primarily active in the life sciences and medical technology industries.

What is the business model of Stratec Se?

The business model of Stratec SE revolves around providing innovative solutions and services to the diagnostics industry. As a leading global technology partner, Stratec SE specializes in developing and producing automated analyzer systems that enable fast, reliable, and cost-effective diagnostics. By focusing on instrument and assay integration, Stratec SE helps its customers streamline their processes and improve laboratory efficiency. The company's comprehensive portfolio covers a wide range of applications, including clinical diagnostics, blood banking, and pharmaceutical quality control. With its expertise and cutting-edge technologies, Stratec SE aims to drive advancements in diagnostics and contribute to improving patient care worldwide.

What is the P/E ratio of Stratec Se 2025?

The P/E ratio cannot be calculated for Stratec Se at the moment.

What is the P/S ratio of Stratec Se 2025?

The P/S cannot be calculated for Stratec Se currently.

What is the Quality Investing of Stratec Se?

The Quality Investing for Stratec Se is 3/10.

What is the revenue of Stratec Se 2025?

The expected Stratec Se revenue is 275.4 M EUR.

How high is the profit of Stratec Se 2025?

The expected Stratec Se profit is 23.6 M EUR.

What is the business model of Stratec Se

Stratec SE is a leading provider of automation solutions for the diagnostic and analytic industry. The company offers a wide portfolio of products and services that are part of its core business. Stratec operates in two business segments: instrumentation and diagnostics. (Instrumentation) Stratec offers a wide range of automation solutions, including the development, production, and distribution of equipment and systems for automated sample processing in clinical laboratories, as well as industrial automation for the production of medical devices and system solutions in the fields of life science and diagnostics. The company is a market leader in immunology and hematology and is also present in other segments such as microbiology and molecular biology. (Diagnostics) The diagnostic business segment provides specialized immunological and molecular tests for a variety of medical applications in the in vitro diagnostic (IVD) market. The company focuses on immuno-oncology, gastroenterology, infectious diseases, and cardiovascular diseases. Stratec offers comprehensive development, production, quality control, life cycle, and market release management services. The company emphasizes close collaboration with its customers to develop innovative solutions of the highest quality that meet the highest requirements for precision, reliability, and scalability. Stratec has demonstrated its resilience, successfully navigating through the COVID-19 pandemic in 2020. The company has proven to be crisis-resistant and has guided its employees through the crisis. With a strong global presence and industry-specific expertise, Stratec is able to continuously meet customer requirements. The company has established its business in the United Kingdom and the United States and plans to expand into other countries, primarily in Asia. Wherever Stratec operates, it emphasizes open and collaborative partnerships with customers and other stakeholders. Overall, Stratec SE is a company that impresses with its comprehensive automation solutions for the diagnostic and analytic industry. The instrumentation business segment covers multiple areas of medicine, while the diagnostics business segment specializes in the development and production of diagnostic solutions. Together, both segments enable optimal collaboration with customers and comprehensive expertise in the industry. The company is capable of addressing both customer needs and industry requirements as a whole.

What is the Stratec Se dividend?

Stratec Se pays a dividend of 0.95 EUR distributed over 1 payouts per year.

How often does Stratec Se pay dividends?

Stratec Se pays out a dividend 1 times a year.

What is the Stratec Se ISIN?

The ISIN of Stratec Se is DE000STRA555.

What is the Stratec Se WKN?

The WKN of Stratec Se is STRA55.

What is the Stratec Se ticker?

The ticker of Stratec Se is SBS.DE.

How much dividend does Stratec Se pay?

Over the past 12 months, Stratec Se paid a dividend of 0.97 EUR . This corresponds to a dividend yield of about . For the coming 12 months, Stratec Se is expected to pay a dividend of 1.05 EUR.

What is the dividend yield of Stratec Se?

The current dividend yield of Stratec Se is .

When does Stratec Se pay dividends?

Stratec Se pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Stratec Se?

Stratec Se paid dividends every year for the past 0 years.

What is the dividend of Stratec Se?

For the upcoming 12 months, dividends amounting to 1.05 EUR are expected. This corresponds to a dividend yield of 3.5 %.

In which sector is Stratec Se located?

Stratec Se is assigned to the 'Health' sector.

Wann musste ich die Aktien von Stratec Se kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stratec Se from 5/22/2024 amounting to 0.55 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Stratec Se pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of Stratec Se in the year 2024?

In the year 2024, Stratec Se distributed 0.97 EUR as dividends.

In which currency does Stratec Se pay out the dividend?

The dividends of Stratec Se are distributed in EUR.

All fundamentals about Stratec Se

Our stock analysis for Stratec Se Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stratec Se Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.